181 related articles for article (PubMed ID: 2986401)
1. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
Ohzeki T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):485-90. PubMed ID: 2986401
[TBL] [Abstract][Full Text] [Related]
2. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
Blackett PR; Seely JR; Altmiller DH; Males JL
Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
[TBL] [Abstract][Full Text] [Related]
3. Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.
Uttley WS; Atkinson B; Adams A; Shirling D
J Inherit Metab Dis; 1978; 1(2):75-7. PubMed ID: 229343
[TBL] [Abstract][Full Text] [Related]
4. Familial cases of congenital nephrogenic diabetes insipidus type II: Remarkable increment of urinary adenosine 3',5'-monophosphate in response to antidiuretic hormone.
Ohzeki T; Igarashi T; Okamoto A
J Pediatr; 1984 Apr; 104(4):593-5. PubMed ID: 6323666
[No Abstract] [Full Text] [Related]
5. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
Becker DJ; Foley TP
J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
[TBL] [Abstract][Full Text] [Related]
6. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
Moses AM; Scheinman SJ; Schroeder ET
Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
Czakó L; Julesz J; László FA
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
[TBL] [Abstract][Full Text] [Related]
9. Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Effect of vasopressin and chlorpropamide.
Raij K; Perheentupa J; Härkönen M
Scand J Clin Lab Invest; 1974 Oct; 34(2):177-84. PubMed ID: 4370673
[No Abstract] [Full Text] [Related]
10. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
[TBL] [Abstract][Full Text] [Related]
11. Augmentation by chlorpropamide of 1-deamino-8-D-arginine vasopressin-induced antidiuresis and stimulation of renal medullary adenylate cyclase and accumulation of adenosine 3',5'-monophosphate.
Moses AM; Coulson R
Endocrinology; 1980 Mar; 106(3):967-72. PubMed ID: 6243558
[TBL] [Abstract][Full Text] [Related]
12. Role of renal prostaglandins during antidiuresis and water diuresis in man.
Walker RM; Brown RS; Stoff JS
Kidney Int; 1982 Feb; 21(2):365-70. PubMed ID: 6951096
[TBL] [Abstract][Full Text] [Related]
13. A case of familial central diabetes insipidus: the response of urinary prostaglandins to 1-deamino-8-D-arginine vasopressin.
Sasaki Y; Higashihara E; Takeuchi T; Nutahara K; Homma Y; Aso Y
J Urol; 1994 Jul; 152(1):161-3. PubMed ID: 8201652
[TBL] [Abstract][Full Text] [Related]
14. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.
Bardoux P; Bichet DG; Martin H; Gallois Y; Marre M; Arthus MF; Lonergan M; Ruel N; Bouby N; Bankir L
Nephrol Dial Transplant; 2003 Mar; 18(3):497-506. PubMed ID: 12584270
[TBL] [Abstract][Full Text] [Related]
16. Basal and hormone-induced urinary cyclic AMP in children with renal disorders.
Monn E; Osnes JB; Oye I
Acta Paediatr Scand; 1976 Nov; 65(6):739-45. PubMed ID: 187004
[TBL] [Abstract][Full Text] [Related]
17. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
Radó JP; Marosi J; Fischer J; Takó J; Kiss N
Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
[TBL] [Abstract][Full Text] [Related]
19. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.
Bichet DG; Razi M; Arthus MF; Lonergan M; Tittley P; Smiley RK; Rock G; Hirsch DJ
Kidney Int; 1989 Nov; 36(5):859-66. PubMed ID: 2559238
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
Lee WP; Lippe BM; La Franchi SH; Kaplan SA
Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
